Skip to main content
. 2015 Jan 14;21(2):661–666. doi: 10.3748/wjg.v21.i2.661

Table 1.

Baseline demographic and clinical characteristics

Characteristic BOACT (n = 104) BOTMO (n = 104)
Male/Female 32/72 39/65
Age (yr) 41.6 ± 12.2 39.6 ± 11.8
Smoking, n (%)
Yes 28 (26.9) 27 (26.0)
No 76 (73.1) 77 (74.0)
Initial eradication regimen, n (%)
BOAC 82 (78.8) 75 (72.1)
BOAM 22 (21.2) 29 (27.9)

BOAC: Bismuth subcitrate, omeprazole, amoxicillin, clarithromycin; BOACT: Bismuth subcitrate, omeprazole, amoxicillin, clarithromycin, tinidazole; BOAM: Bismuth subcitrate, omeprazole, amoxicillin, metronidazole; BOTMO: Bismuth subcitrate, omeprazole, tetracycline, metronidazole, ofloxacin.